With 46,000 employees in 60 countries, Teva ranks among the 10 top pharmaceutical companies in the world. Established in 1901 in Israel, Teva develops, produces and markets a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients and novel therapeutic entities. It produces more than 1,000 molecules and 73 billion tablets and capsules at 73 manufacturing plants every year. It is the US generics market leader, with approximately 20% market share. It pursues robust organic growth, a strategy complemented by key alliances with exemplary partners. It aims to balance investment in growth with return to its investors.